dapsone has been researched along with thalidomide in 63 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (36.51) | 18.7374 |
| 1990's | 6 (9.52) | 18.2507 |
| 2000's | 14 (22.22) | 29.6817 |
| 2010's | 17 (26.98) | 24.3611 |
| 2020's | 3 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bera, S; Mondal, D | 1 |
| Jopling, WH | 1 |
| Jolliffe, DS | 1 |
| Girdhar, A; Ramu, G | 1 |
| Rea, TH; Taylor, CR | 1 |
| Levan, NE; Rea, TH | 1 |
| Jacobson, RR; Trautman, JR | 1 |
| Trautman, JR | 1 |
| Sheskin, J | 1 |
| Browne, SG | 4 |
| Bahmer, FA | 1 |
| Berg, RE; Lo, JS; Tomecki, KJ | 1 |
| Gajl-Peczalska, KJ; Good, RA; Jacobson, RR; Lim, SD | 1 |
| Rohde, R | 1 |
| Sagher, F; Sheskin, J | 1 |
| Civier, A; Hensby, CN; Maloubier, A; Ortonne, JP; Shroot, B | 1 |
| Rea, TH; Yoshida, T | 1 |
| Brazin, SA | 1 |
| Belehu, A; Haregewoin, A; Mshana, RN | 1 |
| Borkowsky, W; Bullock, WE; Frey, HM; Gershon, AA | 1 |
| Gidoh, M; Saito, H | 1 |
| Jorizzo, JL; Mangelsdorf, HC; White, WL | 1 |
| Kaplan, G; Malta, AM; Sampaio, EP; Sarno, EN | 1 |
| Gómez Jiménez, G; López Bueno, R; Velázquez de Castro y Sagarra, A | 1 |
| Ahern, KP; Cabrera, A; Levis, WR; Vides, EA | 1 |
| Boisseau-Garsaud, AM; Garsaud, P; Helenon, R; Quist, D; Saint-Cyr, I; Vezon, G | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Kapp, A; Kiehl, P; Petering, H; Sticht-Groh, V; Vogelbruch, M; Werfel, T | 1 |
| Rea, TH | 1 |
| Duong, DJ; Gaspari, AA; Kellman, RM; Moxley, RT; Pincus, SH | 1 |
| Charte González, A; Folch Civit, J; Robert Olalla, J; Rufi Rigau, G; Sanuy Jiménez, B; Vidaller Palacín, A | 1 |
| Crawford, CL | 1 |
| Ayoub, N; Barete, S; Francès, C; Piette, JC | 1 |
| Aranda, J; Cohen, JB; Hoang, MP | 1 |
| Bieber, T; Tüting, T; Uerlich, M; Wenzel, J | 1 |
| Chawla, S; Moots, RJ; Smart, CJ | 1 |
| Hirota, SK; Migliari, DA; Mimura, MA; Sanches, JA; Sugaya, NN | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Chalmers, RJ; Reddick, CL; Singh, MN | 1 |
| Chang, AY; Werth, VP | 1 |
| Georgakopoulou, EA; Scully, C | 1 |
| Barbieri, KP; Carlos, IZ; Chelucci, RC; Chung, MC; de Faria Fernandes Belone, A; de Melo, TR; Diório, SM; do Nascimento, DC; dos Santos, JL; Placeres, MC; Rosa, PS; Yamasaki, PR | 1 |
| Cantarini, L; Galeazzi, M; Iannone, F; Lapadula, G; Lopalco, G; Rotondo, C; Talarico, R; Vitale, A | 1 |
| Garza-Mayers, AC; McClurkin, M; Smith, GP | 1 |
| Aberer, E; Bata-Csörgő, Z; Caproni, M; Dreher, A; Frances, C; Gläser, R; Klötgen, HW; Kuhn, A; Landmann, A; Marinovic, B; Nyberg, F; Olteanu, R; Ranki, A; Szepietowski, JC; Volc-Platzer, B | 1 |
| Carter, JD; Patel, AA; Raturi, R | 1 |
| Nutan, F; Ortega-Loayza, AG | 1 |
| Harr, T; Lerch, M; Mainetti, C; Terziroli Beretta-Piccoli, B | 1 |
| da Costa Nery, JA; Pereira Cardozo, MR; Tavares Rodrigues, F | 1 |
| McLarnon, JG | 1 |
| Cantarini, L; Emmi, G; Espinosa, G; Hernández-Rodríguez, J; Manna, R; Soriano, A; Soriano, M | 1 |
| Barroso, DH; Bezerra, NVF; Cerqueira, SRPS; Collin, SM; Cunha, DV; Deps, PD; Gomes, CM; Kurizky, PS; Pillegi, GS; Pinheiro, ABS; Repsold, TAR | 1 |
| Fang, YH; Wei, KC; Yu, MS | 1 |
21 review(s) available for dapsone and thalidomide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Leprosy reactional states and their treatment.
Topics: Antigen-Antibody Complex; Clofazimine; Dapsone; Humans; Immunity, Cellular; Leprosy; Prednisolone; Thalidomide | 1977 |
Treatment of discoid lupus erythematosus.
Topics: Antimalarials; Dapsone; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Lupus Erythematosus, Discoid; Retinoids; Sunscreening Agents; Thalidomide | 1989 |
The evaluation of present antileprosy compounds.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Foot; gamma-Globulins; Glucocorticoids; Humans; Immunosuppressive Agents; Immunotherapy; Leprosy; Mice; Muramidase; Mycobacterium leprae; Phenazines; Sulfonamides; Sulfones; Thalidomide; Thioacetazone | 1969 |
Summary of recent abstracts. 8. Leprosy.
Topics: Animals; Antibody Formation; BCG Vaccine; Dapsone; Disease Models, Animal; Guinea Pigs; Humans; Leprosy; Mice; Mycobacterium leprae; Peripheral Nervous System Diseases; Serologic Tests; Thalidomide | 1970 |
Summary of recent abstracts. 8. Leprosy.
Topics: Animals; Dapsone; Disease Models, Animal; Humans; Leprosy; Mice; Phenazines; Thalidomide | 1971 |
Leprosy (Hansen's disease).
Topics: Clofazimine; Dapsone; Ear Deformities, Acquired; Humans; Leprosy; Mouth Diseases; Nose Deformities, Acquired; Rifampin; Thalidomide | 1982 |
[Present status of studies on antileprosy drugs].
Topics: Animals; Clarithromycin; Dapsone; Drug Therapy, Combination; Humans; Immunologic Factors; Leprostatic Agents; Minocycline; Prothionamide; Quinolones; Rifampin; Rifamycins; Thalidomide | 1995 |
[Behcet's disease therapy review].
Topics: Behcet Syndrome; Colchicine; Dapsone; Humans; Methotrexate; Prednisone; Thalidomide | 2002 |
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimalarials; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dapsone; Dermatologic Agents; Female; Gold; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Cutaneous; Male; Methotrexate; Plasmapheresis; Pregnancy; Retinoids; Thalidomide; Time Factors | 2003 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Treatment of cutaneous lupus.
Topics: Administration, Topical; Antimalarials; Calcineurin Inhibitors; Dapsone; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Sunscreening Agents; Thalidomide | 2011 |
Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.
Topics: Anti-Infective Agents; Calcineurin Inhibitors; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Drug Interactions; Drug Monitoring; Facial Dermatoses; Humans; Immunosuppressive Agents; Mouth Diseases; Tacrolimus; Thalidomide; Tubulin Modulators | 2015 |
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.
Topics: Anti-Bacterial Agents; Azathioprine; Behcet Syndrome; Colchicine; Dapsone; Humans; Interferon-alpha; Interleukin-1; Recurrence; Skin; Thalidomide; Tumor Necrosis Factor-alpha | 2015 |
Review of treatment for discoid lupus erythematosus.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Dapsone; Humans; Hydroxychloroquine; Laser Therapy; Lupus Erythematosus, Discoid; Methotrexate; Phototherapy; Retinoids; Smoking Cessation; Thalidomide | 2016 |
Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis.
Topics: Adolescent; Adult; Dapsone; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methotrexate; Mycophenolic Acid; Thalidomide; Treatment Outcome | 2017 |
Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antimalarials; Calcineurin Inhibitors; Dapsone; Humans; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Thalidomide | 2017 |
Current Perspectives on Erythema Multiforme.
Topics: Acyclovir; Dapsone; Drug-Related Side Effects and Adverse Reactions; Erythema Multiforme; Herpes Simplex; Histiocytes; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Practice Guidelines as Topic; Simplexvirus; Skin; T-Lymphocytes; Thalidomide | 2018 |
Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Dapsone; Drug Therapy, Combination; Humans; Ibuprofen; Inflammation; Minocycline; Neuroprotective Agents; Thalidomide | 2019 |
Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.
Topics: Animals; Autoimmune Diseases; Biological Therapy; Colchicine; Dapsone; Evidence-Based Medicine; Fever; Humans; Immunotherapy; Lymphadenitis; Pharyngitis; Randomized Controlled Trials as Topic; Stomatitis, Aphthous; Syndrome; Thalidomide | 2020 |
5 trial(s) available for dapsone and thalidomide
| Article | Year |
|---|---|
The evaluation of present antileprosy compounds.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Foot; gamma-Globulins; Glucocorticoids; Humans; Immunosuppressive Agents; Immunotherapy; Leprosy; Mice; Muramidase; Mycobacterium leprae; Phenazines; Sulfonamides; Sulfones; Thalidomide; Thioacetazone | 1969 |
[Current state of thalidomide treatment of leprosy and leprosy reaction].
Topics: Clinical Trials as Topic; Dapsone; Drug Synergism; Female; Glucocorticoids; Humans; Leprosy; Male; Placebos; Thalidomide | 1970 |
Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Humans; Interferon-gamma; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Mycobacterium leprae; Recombinant Proteins; Rifampin; Skin; Thalidomide | 1996 |
Effect of zafirlukast on leprosy reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Clofazimine; Cohort Studies; Dapsone; Erythema Nodosum; Female; Humans; Indoles; Leprostatic Agents; Leprosy; Leukotriene Antagonists; Male; Middle Aged; Nerve Degeneration; Phenylcarbamates; Prednisone; Rifampin; Sulfonamides; Thalidomide; Tosyl Compounds | 1999 |
Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial.
Topics: Adolescent; Adult; Aged; Child; Colchicine; Dapsone; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pentoxifylline; Recurrence; Severity of Illness Index; Stomatitis, Aphthous; Thalidomide; Treatment Outcome; Young Adult | 2009 |
38 other study(ies) available for dapsone and thalidomide
| Article | Year |
|---|---|
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Management of sulphone-resistant lepromatous leprosy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Thalidomide | 1977 |
Workshop on "chemotherapy of leprosy" at the Central Leprosy Teaching and Research Institute, Chengalpattu (Tamil Nadu) on 21 January 1978.
Topics: Clofazimine; Dapsone; Humans; India; Leprosy; Recurrence; Rifampin; Thalidomide | 1979 |
Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Male; Recurrence; Steroids; Thalidomide; Time Factors | 1979 |
Serum and tissue lysozyme in leprosy.
Topics: Adolescent; Adult; Aged; Dapsone; Histiocytes; Humans; Leprosy; Middle Aged; Muramidase; Radiation-Protective Agents; Thalidomide | 1977 |
Lucio's phenomenon and diffuse nonnodular lepromatous leprosy.
Topics: Adult; Dapsone; Erythema Nodosum; Female; Humans; Ischemia; Leprosy; Lymphopenia; Male; Middle Aged; Necrosis; Retrospective Studies; Skin; Thalidomide | 1978 |
The diagnosis and treatment of leprosy.
Topics: Biopsy; Clofazimine; Dapsone; Erythema Nodosum; Humans; Immunotherapy; Leprosy; Recurrence; Rifampin; Sensation; Skin; Thalidomide; United States | 1976 |
Treatment of Hansen's disease.
Topics: Chloroquine; Clofazimine; Dapsone; Drug Resistance, Microbial; Erythema Nodosum; Humans; Leprosy; Prednisone; Rifampin; Thalidomide | 1976 |
Thalidomide in lepra reaction.
Topics: Dapsone; Humans; Leprosy; Thalidomide | 1975 |
The drug treatment of leprosy.
Topics: Acute Disease; Adrenal Cortex Hormones; Aniline Compounds; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Rifampin; Thalidomide; Thiourea | 1975 |
[Therapy of lymphocytic infiltration].
Topics: Azathioprine; Clofazimine; Cyclosporine; Dapsone; Humans; Levamisole; Lymphocytosis; Skin; Skin Diseases; Thalidomide | 1992 |
B lymphocytes in lepromatous leprosy.
Topics: Adult; Aged; B-Lymphocytes; Dapsone; Fluorescent Antibody Technique; Humans; Immune Sera; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Leprosy; Leukocyte Count; Middle Aged; Prednisolone; Thalidomide | 1973 |
[Initial clinical results using new, experimentally developed therapeutic forms in leprosy].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Dapsone; Drug Therapy, Combination; Ethiopia; Female; Histocytochemistry; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Skin; Sulfonamides; Thalidomide; Time Factors; Trimethoprim | 1973 |
WHO expert committee on leprosy.
Topics: Attitude to Health; BCG Vaccine; Dapsone; Disability Evaluation; Disease Models, Animal; Health Education; Humans; Lepromin; Leprosy; Medical Records; Social Isolation; Sulfonamides; Sulfones; Thalidomide; World Health Organization | 1970 |
A model for studying the anti-prostaglandin activity of drugs in human skin.
Topics: Adult; Aged; Arachidonic Acids; Dapsone; Furans; Humans; Indomethacin; Male; Middle Aged; Nicotinic Acids; Piperazines; Prednisolone; Prostaglandin Antagonists; Prostaglandins; Skin; Thalidomide | 1984 |
Serum macrophage migration inhibition activity in patients with leprosy.
Topics: Dapsone; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Leprosy; Macrophage Migration-Inhibitory Factors; Molecular Weight; Muramidase; Prednisone; Thalidomide | 1982 |
Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.
Topics: Antibodies, Monoclonal; Dapsone; Erythema Nodosum; Humans; Leprosy; Lymphocyte Activation; Mycobacterium leprae; Rifampin; T-Lymphocytes; Thalidomide | 1982 |
Fatal reaction to dapsone during treatment of leprosy.
Topics: Adolescent; Dapsone; Erythema; Humans; Leprosy; Male; Skin; Thalidomide | 1981 |
Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Colchicine; Dapsone; Dermatologic Agents; Female; Genital Diseases, Female; Genital Diseases, Male; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intralesional; Male; Methotrexate; Middle Aged; Neutrophils; Retrospective Studies; Skin Ulcer; Stomatitis, Aphthous; Thalidomide; United States; Vasculitis, Leukocytoclastic, Cutaneous | 1996 |
[Suspected leprosy].
Topics: Adult; Aged; Aged, 80 and over; Dapsone; Diagnosis, Differential; Female; Humans; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Rifampin; Spain; Thalidomide | 1997 |
High prevalence of vitiligo in lepromatous leprosy.
Topics: Adult; Aged; Aged, 80 and over; Clofazimine; Dapsone; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Martinique; Middle Aged; Prevalence; Retrospective Studies; Rifampin; Thalidomide; Vitiligo | 2000 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
[Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
Topics: Adult; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Erythema Nodosum; Follow-Up Studies; Humans; Immunosuppressive Agents; Leprostatic Agents; Leprosy, Lepromatous; Male; Prothionamide; Rifampin; Thalidomide; Time Factors | 2001 |
Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy.
Topics: Anemia; Dapsone; Erythema Nodosum; Hemoglobins; Humans; Leprostatic Agents; Leprosy, Lepromatous; Prednisone; Retrospective Studies; Serum Albumin; Thalidomide | 2001 |
Thalidomide therapy for cicatricial pemphigoid.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatologic Agents; Humans; Immunosuppressive Agents; Laryngeal Diseases; Male; Pemphigoid, Benign Mucous Membrane; Pharyngeal Diseases; Thalidomide | 2002 |
The schizophrenic career of a "monster drug".
Topics: Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Nervous System Diseases; Pyoderma Gangrenosum; Thalidomide | 2003 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Combinations; Female; Glucosamine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infant, Newborn; Isotretinoin; Keratolytic Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Male; Middle Aged; Skin; Sulfasalazine; Thalidomide; Thrombosis; Ultraviolet Therapy; Vasculitis | 2003 |
Shiny red-brown papules in a 21-year-old man. Histoid leprosy.
Topics: Adult; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Face; Humans; Leprostatic Agents; Leprosy; Male; Rifampin; Skin Diseases; Thalidomide | 2004 |
Recto-vaginal fistula: a refractory complication of Behcet's disease.
Topics: Adult; Antibodies, Monoclonal; Behcet Syndrome; Dapsone; Disease Progression; Female; Humans; Inflammation; Infliximab; Rectovaginal Fistula; Thalidomide; Treatment Outcome | 2007 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Comorbidity; Cyclosporine; Dapsone; Hidradenitis Suppurativa; Humans; Infliximab; Male; Methylprednisolone; Middle Aged; Minocycline; Prednisolone; Pyoderma Gangrenosum; Thalidomide; Treatment Outcome | 2010 |
Synthesis and evaluation of novel dapsone-thalidomide hybrids for the treatment of type 2 leprosy reactions.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Dapsone; Dose-Response Relationship, Drug; Humans; Leprosy; Mice; Mice, Nude; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium leprae; Structure-Activity Relationship; Thalidomide | 2014 |
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
Topics: Adrenal Cortex Hormones; Antimalarials; Biological Products; Calcineurin Inhibitors; Consensus; Dapsone; Humans; Immunosuppressive Agents; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Practice Guidelines as Topic; Retinoids; Thalidomide | 2017 |
Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.
Topics: Antifungal Agents; Brazil; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Prednisone; Recurrence; Rifampin; Terbinafine; Thalidomide; Tinea; Trichophyton; Young Adult | 2018 |
The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study.
Topics: Adrenal Cortex Hormones; BCG Vaccine; Brazil; Clofazimine; Cohort Studies; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Dapsone; Humans; Leprosy; Pentoxifylline; Prospective Studies; Risk Factors; SARS-CoV-2; Survival Analysis; Thalidomide | 2021 |
Improvement of erythema elevatum diutinum refractory to dapsone following treatment for underlying multiple myeloma.
Topics: Antineoplastic Agents; Bortezomib; Dapsone; Dermatologic Agents; Dexamethasone; Humans; Male; Middle Aged; Multiple Myeloma; Thalidomide; Vasculitis, Leukocytoclastic, Cutaneous | 2021 |